Hypoxia preconditioning of tissue-engineered mucosa enhances its angiogenic capacity in vitro

Tissue Engineering - Part A

Volumn 17, Issue 11-12, 2011, Pages 1583-1593

  Perez Amodio, Soledad ^a   Tra, Wendy M W ^a   Rakhorst, Hinne A ^a   Hovius, Steven E R ^a   Van Neck, Johan W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELL CULTURE; CELL PROLIFERATION; ENZYME INHIBITION; PEPTIDES; PHYSIOLOGY; TISSUE;

ANGIOGENESIS; ANGIOGENIC CAPACITY; ANGIOGENIC FACTOR; CONDITIONED MEDIUM; CRITICAL PARAMETER; GROWTH FACTOR; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOLOCALIZATION; IN-VITRO; IN-VIVO; KERATINOCYTES; MATRIX; MATRIX METALLOPROTEINASE-9; ORAL MUCOSA; PLASTIC SURGERY; TEM; TISSUE INHIBITOR; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

ENDOTHELIAL CELLS;

ANGIOGENIC FACTOR; GELATINASE A; GELATINASE B;

ANGIOGENESIS; ANIMAL; ARTICLE; CELL COUNT; CELL HYPOXIA; CELL MOTION; CELL PROLIFERATION; CELL STRAIN 3T3; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MOUTH MUCOSA; PATHOLOGY; REPRODUCIBILITY; TISSUE ENGINEERING; UMBILICAL VEIN; VASCULARIZATION;

3T3 CELLS; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL COUNT; CELL HYPOXIA; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MOUTH MUCOSA; NEOVASCULARIZATION, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS; TISSUE ENGINEERING; UMBILICAL VEINS;

EID: 79957614431     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0429     Document Type: Article

References (54)

1. Neligan, P.C., Gullane, P.J., and Gilbert, R.W. Functional reconstruction of the oral cavity. World J Surg 27, 856, 2003.
2. Avery, C.M., Pereira, J., and Brown, A.E. Suprafascial dissection of the radial forearm flap and donor site morbidity. Int J Oral Maxillofac Surg 30, 37, 2001.
3. Graham, B., Adkins, P., and Scheker, L.R. Complications and morbidity of the donor and recipient sites in 123 lateral arm flaps. J Hand Surg Br 17, 189, 1992.
4. Kimata, Y., Uchiyama, K., Ebihara, S., Saikawa, M., Hayashi, R., Haneda, T., Ohyma, W., Kishimoto, S., Asai, M., Nakatsuka, T., and Harii, K. Postoperative complications and functional results after total glossectomy with microvascular reconstruction. Plast Reconstr Surg 106, 1028, 2000.
5. Cho, K.H., Ahn, H.T., Park, K.C., Chung, J.H., Kim, S.W., Sung, M.W., Kim, K.H., Chung, P.H., Eun, H.C., and Youn, J.I. Reconstruction of human hard-palate mucosal epithelium on de-epidermized dermis. J Dermatol Sci 22, 117, 2000.
6. Yoshizawa, M., Feinberg, S.E., Marcelo, C.L., and Elner, V.M. Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system. J Oral Maxillofac Surg 62, 980, 2004.
7. Ophof, R., van Rheden, R.E., Von den, H.J., Schalkwijk, J., and Kuijpers-Jagtman, A.M. Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue. Biomaterials 23, 3741, 2002.
8. Moharamzadeh, K., Brook, I.M., Van Noort, R., Scutt, A.M., and Thornhill, M.H. Tissue-engineered oral mucosa: a review of the scientific literature. J Dent Res 86, 115, 2007.
9. Rakhorst, H.A., Posthumus-Van Sluijs, S.J., Tra, W.M., Van Neck, J.W., Van Osch, G.J., Hovius, S.E., El Ghalbzouri, A., and Hofer, S.O. Fibroblasts accelerate culturing of mucosal substitutes. Tissue Eng 12, 2321, 2006.
10. Izumi, K., Song, J., and Feinberg, S.E. Development of a tissue-engineered human oral mucosa: from the bench to the bed side. Cells Tissues Organs 176, 134, 2004.
11. Ophof, R., Maltha, J.C., Kuijpers-Jagtman, A.M., and Von den Hoff, J.W. Implantation of tissue-engineered mucosal substitutes in the dog palate. Eur J Orthod 30, 1, 2008.
12. Boyce, S.T., Supp, A.P., Harriger, M.D., Greenhalgh, D.G., and Warden, G.D. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J Invest Dermatol 104, 345, 1995.
13. Sumi, Y., Hata, K.I., Sawaki, Y., Mizuno, H., and Ueda, M. Clinical application of cultured oral epithelium for palatal wounds after palatoplasty: a preliminary report. Oral Dis 5, 307, 1999.
14. Kelly, B.D., Hackett, S.F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P.A., and Semenza, G.L. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93, 1074, 2003.
15. Kroon, M.E., Koolwijk, P., van der Vecht, B., and van Hinsbergh, V.W. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J Cell Sci 114, 825, 2001.
16. Thangarajah, H., Yao, D., Chang, E.I., Shi, Y., Jazayeri, L., Vial, I.N., Galiano, R.D., Du, X.L., Grogan, R., Galvez, M.G., Januszyk, M., Brownlee, M., and Gurtner, G.C. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA 106, 13505, 2009.
17. Thangarajah, H., Vial, I.N., Chang, E., El-Ftesi, S., Januszyk, M., Chang, E.I., Paterno, J., Neofytou, E., Longaker, M.T., and Gurtner, G.C. IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem cells (Dayton, Ohio) 27, 266, 2009.
18. Rheinwald, J.G., and Green, H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6, 331, 1975.
19. Ponec, M., Weerheim, A., Kempenaar, J., Mommaas, A.M., and Nugteren, D.H. Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res 29, 949, 1988.
20. Rakhorst, H.A., Tra, W.M., Posthumus-Van Sluijs, S.T., Hovius, S.E., Levendag, P.C., Kanaar, R., and Hofer, S.O. Quantitative analysis of radiation-induced DNA break repair in a cultured oral mucosal model. Tissue Eng 12, 3395, 2006.
21. El Ghalbzouri, A., Lamme, E., and Ponec, M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res 310, 189, 2002.
22. Malda, J., Klein, T.J., and Upton, Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng 13, 2153, 2007.
23. Nakanishi, Y., Izumi, K., Yoshizawa, M., Saito, C., Kawano, Y., and Maeda, T. The expression and production of vascular endothelial growth factor in oral mucosa equivalents. Int J Oral Maxillofac Surg 36, 928, 2007.
24. Xu, Q., Izumi, K., Tobita, T., Nakanishi, Y., and Feinberg, S.E. Constitutive release of cytokines by human oral keratinocytes in an organotypic culture. J Oral Maxillofac Surg 67, 1256, 2009.
25. Abaci, H.E., Truitt, R., Luong, E., Drazer, G., and Gerecht, S. Adaptation to oxygen deprivation in cultures of human pluripotent stem cells, endothelial progenitor cells, and umbilical vein endothelial cells. Am J Physiol Cell Physiol 298, C1527, 2010.
26. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K.H., Foidart, J.M., Schaper, W., Charnock-Jones, D.S., Hicklin, D.J., Herbert, J.M., Collen, D., and Persico, M.G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7, 575, 2001.
27. Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., and Isner, J.M. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18, 3964, 1999.
28. Van Hinsbergh, V.W., Engelse, M.A., and Quax, P.H. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26, 716, 2006.
29. Brew, K., Dinakarpandian, D., and Nagase, H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477, 267, 2000.
30. Brew, K., and Nagase, H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 1803, 55, 2010.
31. Egeblad, M., and Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev 2, 161, 2002.
32. Mott, J.D., and Werb, Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16, 558, 2004.
33. Van Hinsbergh, V.W., and Koolwijk, P. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78, 203, 2008.
34. Griffith, C., and George, S. The effect of hypoxia on in vitro prevascularization of a thick soft tissue. Tissue Eng 15, 2423, 2009.
35. Semenza, G.L. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8, 588, 1998.
36. Trentin, D., Hall, H., Wechsler, S., and Hubbell, J.A. Peptidematrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci USA 103, 2506, 2006.
37. Ke, Q., and Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70, 1469, 2006.
38. Semenza, G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15, 551, 1999.
39. Kellner, K., Liebsch, G., Klimant, I., Wolfbeis, O.S., Blunk, T., Schulz, M.B., and Gopferich, A. Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng 80, 73, 2002.
40. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., and Vunjak-Novakovic, G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93, 332, 2006.
41. Das, R., Jahr, H., Van Osch, G., and Farrell, E. The role of hypoxia in MSCs: considerations for regenerative medicine approaches. Tissue Eng 16, 159, 2010.
42. Straseski, J.A., Gibson, A.L., Thomas-Virnig, C.L., and Allen-Hoffmann, B.L. Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen. Wound Repair Regen 17, 606, 2009.
43. Gill, E.M., Straseski, J.A., Rasmussen, C.A., Liliensiek, S.J., Eliceiri, K.W., Ramanujam, N., White, J.G., and Allen-Hoffmann, B.L. Visualization of morphological and molecular features associated with chronic ischemia in bioengineered human skin. Microsc Microanal 16, 117, 2010.
44. Oberley, C.C., Gourronc, F., Hakimi, S., Riordan, M., Bronner, S., Jiao, C., and Dunnwald, M. Murine epidermal side population possesses unique angiogenic properties. Exp Cell Res 314, 720, 2008.
45. Detmar, M., Brown, L.F., Berse, B., Jackman, R.W., Elicker, B.M., Dvorak, H.F., and Claffey, K.P. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108, 263, 1997.
46. Steinbrech, D.S., Longaker, M.T., Mehrara, B.J., Saadeh, P.B., Chin, G.S., Gerrets, R.P., Chau, D.C., Rowe, N.M., and Gittes, G.K. Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation. J Surg Res 84, 127, 1999.
47. Li, T.S., Hamano, K., Suzuki, K., Ito, H., Zempo, N., and Matsuzaki, M. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol 283, H468, 2002.
48. Rosova, I., Dao, M., Capoccia, B., Link, D., and Nolta, J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem cells (Dayton, Ohio) 26, 2173, 2008.
49. Black, A.F., Berthod, F., L'Heureux, N., Germain, L., and Auger, F.A. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 12, 1331, 1998.
50. Supp, D.M., Wilson-Landy, K., and Boyce, S.T. Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J 16, 797, 2002.
51. Sahota, P.S., Burn, J.L., Brown, N.J., and MacNeil, S. Approaches to improve angiogenesis in tissue-engineered skin. Wound Repair Regen 12, 635, 2004.
52. Ponec, M., El Ghalbzouri, A., Dijkman, R., Kempenaar, J., Van der Pluijm, G., and Koolwijk, P. Endothelial network formed with human dermal microvascular endothelial cells in autologous multicellular skin substitutes. Angiogenesis 7, 295, 2004.
53. Trottier, V., Marceau-Fortier, G., Germain, L., Vincent, C., and Fradette, J. IFATS collection: using human adiposederived stem/stromal cells for the production of new skin substitutes. Stem Cells 26, 2713, 2008.
54. Supp, D.M., and Boyce, S.T. Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. J Burn Care Rehabil 23, 10, 2002.